NO961816L - En fremgangsmåte for fremstilling av en virusaktivert fraksjon inneholdende faktor VIII ved hjelp av kromatografiske metoder - Google Patents

En fremgangsmåte for fremstilling av en virusaktivert fraksjon inneholdende faktor VIII ved hjelp av kromatografiske metoder

Info

Publication number
NO961816L
NO961816L NO961816A NO961816A NO961816L NO 961816 L NO961816 L NO 961816L NO 961816 A NO961816 A NO 961816A NO 961816 A NO961816 A NO 961816A NO 961816 L NO961816 L NO 961816L
Authority
NO
Norway
Prior art keywords
virus
factor viii
chromatographic methods
preparing
fraction containing
Prior art date
Application number
NO961816A
Other languages
English (en)
Other versions
NO317112B1 (no
NO961816D0 (no
Inventor
Ales Strancar
Monika Andrea Stadler
Djuro Josic
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6501733&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO961816(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of NO961816L publication Critical patent/NO961816L/no
Publication of NO961816D0 publication Critical patent/NO961816D0/no
Publication of NO317112B1 publication Critical patent/NO317112B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19961816A 1993-11-04 1996-05-03 En fremgangsmate for fremstilling av en virusaktivert fraksjon inneholdende faktor VIII ved hjelp av kromatografiske metoder NO317112B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4337573A DE4337573C1 (de) 1993-11-04 1993-11-04 Verfahren zur Herstellung einer virusinaktivierten Faktor VIII enthaltenden Fraktion mittels chromatographischer Methoden
PCT/EP1994/003258 WO1995012609A1 (de) 1993-11-04 1994-09-30 Verfahren zur herstellung einer virusinaktivierten faktor viii enthaltenden fraktion mittels chromatographischer methoden

Publications (3)

Publication Number Publication Date
NO961816L true NO961816L (no) 1996-05-03
NO961816D0 NO961816D0 (no) 1996-05-03
NO317112B1 NO317112B1 (no) 2004-08-16

Family

ID=6501733

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19961816A NO317112B1 (no) 1993-11-04 1996-05-03 En fremgangsmate for fremstilling av en virusaktivert fraksjon inneholdende faktor VIII ved hjelp av kromatografiske metoder

Country Status (21)

Country Link
EP (1) EP0726907B1 (no)
JP (1) JP3739788B2 (no)
KR (1) KR960705841A (no)
CN (1) CN1109045C (no)
AT (1) ATE228533T1 (no)
AU (1) AU687451B2 (no)
CA (1) CA2175670C (no)
CZ (1) CZ290186B6 (no)
DE (2) DE4337573C1 (no)
ES (1) ES2182846T3 (no)
FI (1) FI116569B (no)
HU (1) HU222087B1 (no)
IL (1) IL111263A (no)
MY (1) MY113294A (no)
NO (1) NO317112B1 (no)
PL (1) PL181725B1 (no)
RU (1) RU2148411C1 (no)
SK (1) SK284215B6 (no)
UA (1) UA43855C2 (no)
WO (1) WO1995012609A1 (no)
ZA (1) ZA948667B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19618851C1 (de) * 1996-05-10 1997-07-24 Octapharma Ag Verfahren zur Eignungsprüfung von Faktor VIII-haltigen Proteinfraktionen
EP0885394B1 (de) * 1996-03-08 2000-08-16 Octapharma AG Verfahren zur eignungsprüfung von faktor viii-haltigen proteinfraktionen
ES2137878B1 (es) * 1997-12-01 2000-10-01 Grifols Grupo Sa Procedimiento de obtencion de un plasma humano atenuado de virus para uso terapeutico.
PL2300497T3 (pl) * 2008-06-24 2013-02-28 Octapharma Ag Sposób oczyszczania czynnika krzepnięcia VIII
US9488625B2 (en) 2010-12-15 2016-11-08 Baxalta GmbH Purification of factor VIII using a conductivity gradient

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US5043428A (en) * 1984-08-31 1991-08-27 Behringwerke Aktiengesellschaft Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
DE3432083A1 (de) * 1984-08-31 1986-03-06 Behringwerke Ag, 3550 Marburg Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung
JPS62191042A (ja) * 1986-02-17 1987-08-21 Kanegafuchi Chem Ind Co Ltd 血液凝固第８因子吸着体およびそれを用いた血液凝固第８因子の精製法
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
US4774323A (en) * 1987-06-29 1988-09-27 Rorer Pharmaceutical Corporation Purification of von Willebrand Factor solutions using gel permeation chromatography
US4795806A (en) * 1987-07-16 1989-01-03 Miles Laboratories, Inc. Phospholipid affinity purification of Factor VIII:C
CA2001720C (en) * 1988-10-31 2001-10-02 Randal A. Goffe Membrane affinity apparatus and purification methods related thereto
ATE85221T1 (de) * 1988-11-05 1993-02-15 Octapharma Ag Verfahren zur herstellung eines hochreinen, nicht infektioesen antihaemophiliefaktors mittels chromatographie.
CH678155A5 (no) * 1989-08-09 1991-08-15 Fischer Ag Georg
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation

Also Published As

Publication number Publication date
ATE228533T1 (de) 2002-12-15
CZ118796A3 (en) 1996-12-11
KR960705841A (ko) 1996-11-08
JP3739788B2 (ja) 2006-01-25
SK56696A3 (en) 1996-10-02
UA43855C2 (uk) 2002-01-15
HU9601192D0 (en) 1996-06-28
AU687451B2 (en) 1998-02-26
EP0726907B1 (de) 2002-11-27
CN1134157A (zh) 1996-10-23
FI961900A0 (fi) 1996-05-03
SK284215B6 (sk) 2004-11-03
HUT76530A (en) 1997-09-29
CZ290186B6 (cs) 2002-06-12
IL111263A0 (en) 1994-12-29
HU222087B1 (hu) 2003-04-28
CA2175670A1 (en) 1995-05-11
JPH09504532A (ja) 1997-05-06
DE4337573C1 (de) 1995-05-18
WO1995012609A1 (de) 1995-05-11
EP0726907A1 (de) 1996-08-21
NO317112B1 (no) 2004-08-16
ES2182846T3 (es) 2003-03-16
DE59410213D1 (de) 2003-01-09
MY113294A (en) 2002-01-31
AU7810994A (en) 1995-05-23
FI116569B (fi) 2005-12-30
NO961816D0 (no) 1996-05-03
ZA948667B (en) 1995-07-07
RU2148411C1 (ru) 2000-05-10
PL314185A1 (en) 1996-09-02
CN1109045C (zh) 2003-05-21
IL111263A (en) 2000-07-16
FI961900A (fi) 1996-05-03
PL181725B1 (pl) 2001-09-28
CA2175670C (en) 2005-08-02

Similar Documents

Publication Publication Date Title
GR3003819T3 (no)
DE359593T1 (de) Chromatographische trennung von plasmaproteinen.
DE69002395D1 (de) N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen.
CA2034489A1 (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
BR9913026A (pt) Processo de purificação de partìculas semelhantes a vìrus (vlps) de papilomavìrus recombinante, e, processo de preparação de um produto de vlp de papilomavìrus humano purificado adequado para uso em uma vacina para humano
DK0429570T3 (da) Osteoinducerende præparater
DE69424545D1 (de) Verfahren zur herstellung von immunoglobulin g konzentrat
NO963785L (no) Fremgangsmåte for behandling av 5HT2B-reseptor-relaterte betingelser
NO961816D0 (no) En fremgangsmåte for fremstilling av en virusaktivert fraksjon inneholdende faktor VIII ved hjelp av kromatografiske metoder
BR9206948A (pt) Processo para remover 2-cloro-1,1-difluor-etileno e outros compostos insaturados de (R-1122) 1,1,1,2-tetra-fluor-etano e co-produção de 2-cloro-1,1,1,2-tetra-fluor-etano
ES2053684T3 (es) Procedimiento para preparar un factor antihemofilico, altamente puro, no infeccioso, mediante cromatografia.
EA199800685A1 (ru) Разделение компонентов плазмы крови с помощью фильтрующих средств на основе целлюлозы
DE69510937D1 (de) Verfahren zur gewinnung von polyhydroxyalkanoaten mittels zentrifugenfraktionerung
AR018260A1 (es) Un proceso para preparar una solucion de gammaglobulina que puede ser administrada por via intravenosa, y solucion de gammaglobulina obtenida por dichoproceso
ES2053619T3 (es) Procedimiento para la fabricacion de un factor antihemofilico de gran pureza y libre de virus mediante cromatografia.
ATE329602T1 (de) Verfahren zur herstellung von gereinigtem transferrin
ATE246250T1 (de) Immunogenes konstrukt, verfahren zu dessen herstellung und verwendung als vakzine
ES2117197T3 (es) Procedimiento para la extraccion y purificacion de alfa1-antitripsina (alfa1-pi) a partir de la fraccion de cohn iv-1.
ES2123570T3 (es) Uso de la molecula de adhesion de leucocitos y endotelios 1 y anticuerpos contra ella en el tratamiento del asma.
DE59407666D1 (de) VERFAHREN ZUR HERSTELLUNG VON 8-g(a),12-OXIDO-13,14,15,16-TETRANORLABDAN
ES2094701A1 (es) Procedimiento para la produccion de antitrombina iii
UA13922A (uk) Спосіб одержаhhя коhтріhсуліhового фактора, який блокує зв'язуваhhя іhсуліhу з його рецептором та має діабетогеhhу дію

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees